Excited-state dynamics of 6-azauracil (6-AU) and sensitized singlet oxygen formation in acetonitrile solution with UV irradiation were investigated for the first time. In the transient absorption measurement, the 248 nm laser photolysis gave a relatively intense absorption band at 320 nm (= 1100 +/- 100 dm(3) mol(-1) cm(-1)) and a broadband in the 500-700 nm region due to triplet 6-AU. The triplet 6-AU, decaying with the rate constant of (5.3 +/- 0.2) x 10(6) s(-1) in Ar saturated acetonitrile, was quenched by molecular oxygen with the rate constant of (2.5 +/- 0.1) x 10(9) dm(3) mol(-1) s(-1). The formation quantum yield of excited triplet 6-AU was estimated to be unity by acetone triplet sensitization and actinometry with benzophenone. The time-resolved thermal lensing signal of 6-AU was also observed by 248 nm laser excitation. In the presence of molecular oxygen, the sensitization from triplet 6-AU gave rise to formation of singlet oxygen O(2) ((1)Delta(g)) with a quantum yield of 0.63 +/- 0.03. Drastically different excited-state dynamics of aza-substituted uracil from normal uracil were clarified, and the mechanism for the enhancement of intersystem crossing by aza-substitution is discussed.

A technique for replication R- and G-banding of mouse lymphocyte chromosomes was developed, and the replication R-banding pattern was analyzed. Optimal banding patterns were obtained with thymidine- and BrdU-treatment of lymphocytes in the same cell cycle. This produced replication R-band patterns that were the complete reverse of the G-band patterns on all chromosomes. Replication R-banding methods can be used in conjunction with nonisotopic, fluorescence in situ hybridization (FISH) to localize cloned probes to specific chromosomal bands on mouse chromosomes. With these methods the mouse complement factor H gene (cfh) was localized to the terminal portion of the F region of Chromosome 1. Q-banding patterns were also obtained by the replication R-banding method and may be useful for rapid identification of each chromosome.

Excited state characteristics of aza analogues of nucleic acid bases, 8-azaadenine (8AA), 5-azacytosine (5AC), 8-azaguanine (8AG), and 6-azauracil (6AU), in acetonitrile solution were comprehensively investigated with steady state absorption and emission spectra, transient absorption measurements, emission measurements for the singlet oxygen molecule, and time-dependent density functional theory (TD-DFT) calculations. The triplet-triplet absorption spectrum of 8AA whose peak was 455 nm was observed for the first time. Sensitized singlet oxygen formation of 8AA was also observed in O(2)-saturated acetonitrile with quantum yields of 0.15 +/- 0.02. It was concluded that there were two kinds of aza analogues of nucleic acid bases: type A had substantial quantum yield for the intersystem crossing and potential of O2 (1Delta(g)) formation (8AA and 6AU), and type B did not (5AC and 8AG). TD-DFT calculations indicated that type A molecules had a dark 1npi* state below the first allowed 1pipi* state, while both S1 and S2 states for type B molecules had a pipi* character. It strongly suggested that the dark 1npi* state below the 1pipi* state would play an important role in the ISC process of aza analogues of nucleic acid bases.

In an attempt to disclose mechanisms of bladder carcinogenesis and discover novel target molecules for development of treatment, we applied a cDNA microarray to screen genes that were significantly transactivated in bladder cancer cells. Among the upregulated genes, we here focused on a novel gene, (DEPDC1) DEP domain containing 1, whose overexpression was confirmed by northern blot and immunohistochemical analyses. Immunocytochemical staining analysis detected strong staining of endogenous DEPDC1 protein in the nucleus of bladder cancer cells. Since DEPDC1 expression was hardly detectable in any of 24 normal human tissues we examined except the testis, we considered this gene-product to be a novel cancer/testis antigen. Suppression of DEPDC1 expression with small-interfering RNA significantly inhibited growth of bladder cancer cells. Taken together, these findings suggest that DEPDC1 might play an essential role in the growth of bladder cancer cells, and would be a promising molecular-target for novel therapeutic drugs or cancer peptide-vaccine to bladder cancers.

Excited-state dynamics of 4-thiothymidine (S4-TdR) and its photosensitization to molecular oxygen in solution with UVA irradiation were investigated. Absorption and emission spectra measurements revealed that UVA photolysis of S4-TdR gives rise to a population of T1(pipi*), following S2(pipi*) --> S1(npi*) internal conversion. In transient absorption measurement, the 355 nm laser photolysis gave broad absorption (380-600 nm) bands of triplet S4-TdR. The time-resolved thermal lensing (TRTL) signal of S4-TdR containing the thermal component due to decay of triplet S4-TdR was clearly observed by the 355 nm laser excitation. The quantum yield for S1 --> T1 intersystem crossing was estimated to be unity by a triplet quenching experiment with potassium iodide. In the presence of molecular oxygen, the photosensitization from triplet S4-TdR gave rise to singlet oxygen O2 (1Deltag) with a quantum yield of 0.50. Therapeutic implications of such singlet oxygen formation are discussed.

Bladder cancer is the second most common genitourinary cancer worldwide, yet its oncogenic origins remain poorly understood. The cancer-testis antigen DEPDC1 was shown recently to contribute to bladder cancer oncogenesis. In this study, we examined the biological functions of DEPDC1 and defined a potential therapeutic strategy to target this molecule. Coimmunoprecipitation and immunocytochemistry revealed that DEPDC1 interacted and colocalized with zinc finger transcription factor ZNF224, a known transcriptional repressor. Inhibiting this interaction with a cell-permeable peptide corresponding to the ZNF224-interacting domain in DEPDC1 induced apoptosis of bladder cancer cells in vitro and in vivo. By inhibiting DEPDC1-ZNF224 complex formation, this peptide triggered transcriptional activation of A20, a potent inhibitor of the NF-κB signaling pathway. Our findings indicate that the DEPDC1-ZNF224 complex is likely to play a critical role in bladder carcinogenesis.

Ultrafast intersystem crossing of UVA-sensitive 4-thiothymidine in aqueous solution was investigated by pump-probe transient absorption. 4-Thiothymidine in the excited singlet state exhibited a distinctively different photophysical pathway from that of thymidine, with intersystem crossing to the triplet manifold being dominant and the triplet formation being completed within approximately 10 ps. This was further supported by quantum chemical calculations. We propose that the unique behavior of photoexcited 4-thiothymidine results from its distinctive molecular and electronic structures and that the triplet form is the initial toxic source to DNA and other biomolecules.

Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder that is characterized by degeneration of the anterior horn cells of the spinal cord, which leads to the axial and limb weakness associated with muscle atrophy. SMA is classified into three groups based on the clinical severity: type I (severe), type II (intermediate) and type III (mild). All three clinical subtypes of SMA are caused by mutations of the SMN1 gene. More than 95 % of SMA patients show homozygous deletion of SMN1. It is thought that SMN2, which is a highly homologous gene of SMN1, compensates for the SMN1 deletion to some degree. To clarify the relationship between SMN2 and the disease severity of SMA, we performed fluorescence-based quantitative polymerase chain reaction assay of the copy number of SMN2 in 27 patients (11 type I and 16 type II-III) homozygous for SMN1 deletion. The SMN2 copy number in type II-III patients was 3.1 +/- 0.3 (mean +/- SD), which is significantly higher than that observed in type I patients, 2.2 +/- 0.6 (P < 0.01). However, three of the 11 type I patients carried 3 SMN2 copies. A type I patient with 3 SMN2 copies was studied further. RT-PCR analysis of the patient showed a trace of full-length SMN2 mRNA species, but a large amount of the truncated SMN2 mRNA species lacking exon 7. In conclusion, SMN2 alleles are not functionally equivalent among SMA patients, although in general the SMN2 copy number is correlated with the severity of SMA. Genetic background influencing splicing mechanisms of the SMN2 gene may be more critical in some SMA patients.